196.61% Upside
Date | Brokerage Firm | Analyst Name | Price Target | Price when Posted | Upside/Downside on Report Date | Details |
---|---|---|---|---|---|---|
07/01/2024 | H.C. Wainwright | Robert Burns | $7.00 | $1.98 | 253.54% |
A. Immix Biopharma, Inc. has been rated by research analysts at H.C. Wainwright in the past 90 days.